Evidence map›Paper›PMID 25313341›Full record

ArticleCase reports in rheumatology2014

Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept.

Fabio E Ospina, Andrés Agualimpia, Fabio Bonilla-Abadía, Carlos A Cañas, Gabriel J Tobón

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in rheumatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trends in the Epidemiology ofJournal of fungi (Basel, Switzerland) · 2023
    Review
  2. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2015
    Review
  3. [Open respiratory archives
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fabio E OspinaInstituto de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia ; Fundación Valle del Lili, Cra 98, No. 18-49, Cali, Colombia.
Andrés AgualimpiaFundación Valle del Lili, Cra 98, No. 18-49, Cali, Colombia.
Fabio Bonilla-AbadíaFundación Valle del Lili, Cra 98, No. 18-49, Cali, Colombia.ORCID 0000-0003-1683-1610
Carlos A CañasFundación Valle del Lili, Cra 98, No. 18-49, Cali, Colombia.
Gabriel J TobónFundación Valle del Lili, Cra 98, No. 18-49, Cali, Colombia.
Fundación Valle del Lili · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial membrane inflammation and joint cartilage destruction. Abatacept is a biologic agent that blocks the costimulation signals, preventing antigen presentation and proliferation of T lymphocytes. It is approved for the treatment of patients with RA. Pneumocystis jirovecii pneumonia (PJP) is an infectious disease complicating several immunosuppressive drugs. PJP associated with abatacept has not been reported yet in the medical literature. Various factors, such as the mechanism of action of abatacept, may contribute to predisposing to  Pneumocystis jirovecii infection. In this paper, we report a patient with RA who developed PJP under abatacept treatment.

Identifiers

PMID25313341
PMCPMC4182847
OpenAlexW2135437605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.